Drug Trial Radar · NCT00095823
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,200
Actual
Start
Jun 2004
Primary completion
Aug 2006
Study completion Aug 2006
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- Collaborators
- Otsuka America Pharmaceutical
- First posted
- Nov 9, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant treatment in patients with Major Depressive Disorder.
Conditions
- Major Depressive Disorder
Interventions
Antidepressant + PlaceboDrug
Antidepressant Caps/Tablets Placebo Tablets, Oral, 2-20 mg Placebo, once daily, 6 weeks following an 8 week Prospective Treatment (Baseline) Phase.
Antidepressant + AripiprazoleDrug
Antidepressant Caps/Tablets Aripiprazole Tablets, Oral, 2-20 mg Aripiprazole, once daily, 6 weeks following an 8 week Prospective Treatment (Baseline) Phase.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in a depression rating scale at endpoint
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Local Institution
Garden Grove, California
Local Institution
Northridge, California
Local Institution
Washington D.C., District of Columbia
Local Institution
Jacksonville, Florida
Local Institution
Chicago, Illinois
Local Institution
Edwardsville, Illinois
Local Institution
Rockville, Maryland
Local Institution
Springfield, Massachusetts
Local Institution
Farmington Hills, Michigan
Local Institution
Okemos, Michigan
Local Institution
Staten Island, New York
Local Institution
Portland, Oregon
Local Institution
Philadelphia, Pennsylvania
Local Institution
Austin, Texas
Local Institution
Salt Lake City, Utah
Local Institution
Woodstock, Vermont
Local Institution
Charlottesville, Virginia
Local Institution
Bellevue, Washington
Local Institution
Seattle, Washington
Local Institution
Middleton, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.